Investor Overview

KindredBio is a biotechnology company that develops medicines for pets. We believe that our animal family members deserve the same great medicines that human family members enjoy.

Stock Information

Change (%) - 0.1 (1.13%)
Data as of 01/31/18 4:00 p.m. ET
Refresh quote
Data provided by Nasdaq. Minimum 15 minutes delayed.


KindredBio Announces Submission of European Medicines Agency Filing for Mirataz™

December 21, 2017

SAN FRANCISCO, Dec. 21, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ... 

KindredBio Announces Positive Results from Pivotal Study of Zimeta Oral for Fever in Horses

December 4, 2017

SAN FRANCISCO, Dec. 4, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K... 

Kindred Biosciences Announces Third Quarter 2017 Financial Results

November 7, 2017

SAN FRANCISCO, Nov. 7, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K...